To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

383.7521 hours ago
391.00a day ago
arrow

LOWER/UPPER CIRCUITS

311.65
467.45
arrow
Medicamen Biotech Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteQuarterly Net profit,rose 13.55% YoY to ₹2.42 Cr. Its sector's average net profit growth YoY for the quarter was 21.52%.
noteInterest Coverage Ratio,is 6.37, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
noteDebt to Equity Ratio,of 0.16 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : %
Net profit growth 5Y CAGR : %
Medicamen Biotech Limited is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. It is a manufacturer and supplier of a range of products such as tablets capsules liquid syrup and dry syrup (beta lactum and non beta lactum) and ointment. Its product offerings include Acarbrose Tablets 50 milligram Acetazolamide Tablet 250 milligram BP Amitriptyline Hcl Tablet 25 milligram Amlodipine Besylate Tablet 10 milligram and Sulfadoxine and Anti Malarial Kit. As of March 31 2012 its production capacity under beta lactum included tablets (eight million per day) capsules (one million per day) oral liquid (4600 liters per day) and dry syrup (6000 kilogram per day). Its production capacity under non beta lactum included tablets (one million per day) capsules (one million per day) liquid (1300 liters per day) and dry syrup (50 000 bottles per day). The Company has two manufacturing at Bhiwadi and Haridwar.
personal

Grow your wealth with more research recommendations

+91